Vitamin D status and prevalent early age-related macular degeneration in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study
- 165 Downloads
Vitamin D status has been hypothesized to protect against development of early age-related macular degeneration (AMD) via its anti-inflammatory properties and its possible beneficial influence on blood pressure control. We investigated the association between vitamin D status and prevalent early AMD in a community-based cohort.
This was a cross-sectional study.
This was a secondary data analysis of already existing data from the Atherosclerosis Risk in Communities Study (ARIC) cohort collected from 1990 to 1995.
There were 9,734 (7,779 Caucasians, 1,955 African American) ARIC participants (aged 46 to 70 at visit 2 [1990-1992]) with 25(OH)D data available at visit 2, AMD assessment at visit 3 (1993-1995), and complete covariate data.
Vitamin D status was assessed with serum 25-hydroxyvitamin D (25(OH)D) concentrations from bloods drawn at visit 2. Prevalent, early AMD (n=511) was assessed at visit 3 (1993-95) with nonmydriatic retinal photographs of one randomly chosen eye. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for early AMD by categories of 25(OH)D in nmol/L (deficient <30, inadequate 30-<50, and two categories of adequate status: 50-<75 and ≥75). Linear trend was estimated using continuous 25(OH)D concentrations. ORs were adjusted for age, race, and smoking status. We further adjusted for hypertension status to examine if vitamin D status influenced early AMD via its effects on blood pressure. Exploratory analyses of effect modification by age, sex, race and high risk genotypes [Y402H complement factor H (CFH) rs1061170 and the A69S age-related maculopathy susceptibility 2 (ARMS2) rs10490924 polymorphisms] were conducted.
The prevalence of early AMD was 5%, and 5% of participants were vitamin D deficient. The adjusted OR (95% CIs) for early AMD among those with adequate (=75 nmol/L) compared to deficient (<30 nmol/L) vitamin D status was 0.94 (0.59-1.50), p-trend=0.86. Further adjustment for hypertension status did not influence results (OR [95% CI]=0.95 [0.59-1.52], p-trend=0.84). Results did not vary significantly by age, race, sex, early AMD subtype (soft drusen or retinal pigment epithelium depigmentation), or ARMS2 genotype. Results did not vary significantly by CFH genotype in African Americans. The p for multiplicative interaction between 25(OH)D and CFH genotype was 0.06 in Caucasians, but OR [95% CIs] for AMD by vitamin D status were similar in each CFH genotype and not statistically significant.
Vitamin D status was not associated with early AMD in this cohort sample.
Keywordsvitamin D 25-hydroxyvitamin D macular degeneration retinal diseases epidemiology cohort studies
- 1.Age-Related Eye Disease Study Research G. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of ophthalmology 2001;119(10):1417–36.CrossRefGoogle Scholar
- 8.Graffe A, Milea D, Annweiler C, Beauchet O, Mauget-Faysse M, Beauchet O, Kodjikian L, Milea D. Association between hypovitaminosis D and late stages of age-related macular degeneration: a case-control study. Journal of the American Geriatrics Society 2012;60(7):1367–9. doi: 10.1111/j.1532-5415.2012.04015.x.CrossRefPubMedGoogle Scholar
- 14.Cougnard-Gregoire A, Merle BM, Korobelnik JF, Rougier MB, Delyfer MN, Feart C, Le Goff M, Dartigues JF, Barberger-Gateau P, Delcourt C. Vitamin D Deficiency in Community-Dwelling Elderly Is Not Associated with Age-Related Macular Degeneration. The Journal of nutrition 2015;145(8):1865–72. doi: 10.3945/jn.115.214387.CrossRefPubMedGoogle Scholar
- 16.IOM (Institute of Medicine). 2011. Summary. In: Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: The National Academy Press: Page 1-14.Google Scholar
- 18.Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001;20(6):705–32.CrossRefPubMedGoogle Scholar
- 21.Millen AE, Meyers KJ, Liu Z, Engelman CD, Wallace RB, Le Blanc ES, Tinker LF, Iyengar SK, Robinson JG, Sarto GE, et al. Association between vitamin D status and age-related macular degeneration by genetic risk. JAMA Ophthalmol 2015;133(10):1171–9. doi: 10.1001/jamaophthalmol.2015.2715.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl):786-806.Google Scholar
- 27.Folsom AR, Roetker NS, Rosamond WD, Heckbert SR, Basu S, Cushman M, Lutsey PL. Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study. Journal of thrombosis and haemostasis: JTH 2014;12(9):1455–60. doi: 10.1111/jth.12665.CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Atherosclerosis Risk in Communities (ARIC) Study Research Group. Manual 8 Lipid and Lipoprotein Determinations. In. Chapell Hill, NC: Atherosclerosis Risk in Communities (ARIC) Study Research Group; 1991.Google Scholar
- 29.Holliday EG, Smith AV, Cornes BK, Buitendijk GH, Jensen RA, Sim X, Aspelund T, Aung T, Baird PN, Boerwinkle E, et al. Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study metaanalysis. PloS one 2013;8(1):e53830. doi: 10.1371/journal.pone.0053830.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, Uitterlinden AG, Harris TB, Witteman JC, Boerwinkle E. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circulation 2009;2(1):73–80.PubMedPubMedCentralGoogle Scholar
- 31.Feneis JF, Arora RR. Role of Vitamin D in Blood Pressure Homeostasis. American journal of therapeutics 2010.Google Scholar
- 33.Seddon JM, Reynolds R, Shah HR, Rosner B. Smoking, Dietary Betaine, Methionine, and Vitamin D in Monozygotic Twins with Discordant Macular Degeneration: Epigenetic Implications. Ophthalmology 2011 May 25. [Epub ahead of print].Google Scholar
- 34.Morrison MA, Silveira AC, Huynh N, Jun G, Smith SE, Zacharaki F, Sato H, Loomis S, Andreoli MT, Adams SM, et al. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Human genomics 2011;5(6):538–68.CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Meleth, A.D., Raiji V.R., Krishnadev N., and Chew E (2011). Therapy of Nonexudative Age-Related Macular Degeneration In Ho, A.C. and Regillo C.D. (Eds.), Age-related Macular Degeneration Diagnosis and Treatment (pp. 65-78). New York, NY: Springer New York.Google Scholar
- 38.Millen AE, Wactawski-Wende J, Pettinger M, Melamed ML, Tylavsky FA, Liu S, Robbins J, LaCroix AZ, LeBoff MS, Jackson RD. Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women’s Health Initiative Calcium plus Vitamin D clinical trial. The American journal of clinical nutrition 2010;91(5):1324–35.CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2010;19(4):927–31. doi: 10.1158/1055-9965.EPI-09-1121.CrossRefPubMedPubMedCentralGoogle Scholar
- 40.Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. American journal of epidemiology 2010;171(8):903–8. doi: 10.1093/aje/kwq005.CrossRefPubMedGoogle Scholar
- 41.Meng JE, Hovey KM, Wactawski-Wende J, Andrews CA, Lamonte MJ, Horst RL, Genco RJ, Millen AE. Intraindividual variation in plasma 25-hydroxyvitamin D measures 5 years apart among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2012;21(6):916–24. doi: 10.1158/1055-9965.EPI-12-0026.CrossRefPubMedPubMedCentralGoogle Scholar
- 42.Atherosclerosis Risk in Communities Study. Exam 2. Derived Variable Dictionary. Version 2.10. June 2010. https://www2.cscc.unc.edu/aric/sites/default/files/public/manuals/DERIVE2_10.pdf (Accessed July 28, 2016).Google Scholar